Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Journal of Veterinary Research
Volume 65 (2021): Numero 1 (March 2021)
Accesso libero
Characterisation of a new molecule based on two E2 sequences from bovine viral diarrhoea-mucosal disease virus fused to the human immunoglobulin Fc fragment
Alaín González Pose
Alaín González Pose
,
Raquel Montesino Seguí
Raquel Montesino Seguí
,
Rafael Maura Pérez
Rafael Maura Pérez
,
Florence Hugues Salazar
Florence Hugues Salazar
,
Ignacio Cabezas Ávila
Ignacio Cabezas Ávila
,
Claudia Altamirano Gómez
Claudia Altamirano Gómez
,
Oliberto Sánchez Ramos
Oliberto Sánchez Ramos
e
Jorge Roberto Toledo
Jorge Roberto Toledo
| 26 gen 2021
Journal of Veterinary Research
Volume 65 (2021): Numero 1 (March 2021)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Articolo
Immagini e tabelle
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
26 gen 2021
Pagine:
27 - 37
Ricevuto:
15 lug 2020
Accettato:
29 dic 2020
DOI:
https://doi.org/10.2478/jvetres-2021-0006
Parole chiave
bovine viral diarrhoea virus
,
adenoviral vector
,
expression system
,
immune response
,
E2 glycoprotein
© 2021 A.G. Pose et al. published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Fig 1
Expression of the bvde2fc gene and assembly of the recombinant adenoviral vector carrying the gene (AdBVDE2Fc)A – Scheme of the transcriptional unit for bvde2fc gene expression. pCMV – early/immediate cytomegalovirus promoter; S – spacer of glycine and serine; H – histidine tag; hFc – Fc segment of human immunoglobulin; bGH poly (A) – sequence of the transcriptional termination from the bovine growth hormone B – Expression assay of the bvde2fc gene by transfecting the pcDNA 3.1- bvde2fc plasmid into HEK-293 cells. MWM – molecular weight marker; 1 – supernatant of HEK-293 cells transduced without plasmid; 2 – supernatant of HEK-293 cells transduced with the pcDNA 3.1- bvde2fc plasmid; WB – Western blot C – Fluorescent halo indicating the correct assembly of AdBVDE2Fc
Fig 2
Expression of the bvde2fc gene by transducing mammalian cell lines from different species with AdBVDE2Fc. 1 – supernatant of non-transduced cells; 2 – supernatant of transduced cells with AdBVDE2Fc at MOI 100
Fig 3
Purification of BVDE2Fc by IMACA – Analysis by SDS-PAGE and Western blot of different steps of the purification process. 1 – initial sample; 2 – unbound material; 3 – wash at 20 mM imidazole; 4 – elution at 80 mM imidazole B – Analysis by SDS-PAGE and Western blot of the purified BVDE2Fc. 1 – in reduced conditions; 2 – in non-reduced conditions C – HPLC size exclusion chromatography of the purified BVDE2Fc. Upper graph – external standard. 1 – 660 kDa; 2 – 440 kDa; 3 – 158 kDa; 4 – 75 kDa; 5 – 43 kDa; 6 – 13.7 kDa. Lower graph – BVDE2Fc. T – tetramers; D – dimers; M – monomers
Fig 4
Analysis of the N-glycan profile released after BVDE2Fc deglycosylationA – N-glycan analysis by a NP-HPLC-Amide 80 column. The N-glycan retention times were expressed as glucose units (GU) by comparison with a standard 2AB-labeled dextran hydrolysate B – N-glycan analysis by HPLC-weak anion exchange chromatography. Blue – N-glycans of IgG as external standard; Red – N-glycans of BVDE2Fc; RT – retention time Inset – SDS-PAGE of BVDE2Fc. 1 – glycosylated with PNGase-F; 2 – deglycosylated with PNGase-F
Fig 5
Characterisation of BVDE2Fc as immunogenA – Humoral immune response after inoculating mice with 20 μg of BVDE2Fc B – Analysis of mice sera by coating with deglycosylated BVDE2Fc in ELISA assays C – Analysis of mice sera by coating with EPOFc in ELISA assays. NC – negative control; NC t:42 – negative control of the pool from mice sera at 42 days. The arrow indicates the second inoculation. Bars represent the standard deviation. OD values were compared by the Kruskal–Wallis test and the Dunn post-test (A, B), and by the Mann–Whitney test (C). * P < 0.05; ** P < 0.01; *** P < 0.001
Fig 6
Evaluation of sera from bovines positive to different BVD-MDV subtypes by coating with BVDE2Fc in ELISA assays. Bars represent the standard deviation. OD values were compared by the Kruskal–Wallis test and the Dunn post-test (A, B), and by the Mann–Whitney test (C). * – P < 0.05; ** – P < 0.01; *** – P < 0.001; AI – animal identification; VS – viral subtype; NC – negative control; ND – not determined; black line – cut-off value
Prediction of N-glycan structures using the Glycostore glycobase
Anteprima